1. 977PThe role of bevacizumab plus front-line chemotherapy in patients with malignant ascites of ovarian cancer. (23rd October 2018) Authors: Nikolaou, M; Ziras, N; Athanasiadis, I; Ardavanis, A; Vaslamatzis, M; Kentepozidis, N; Makrantonakis, P; Christopoulou, A N; Michalaki, V; Polizos, A; Emmanouilidis, C; Georgoulias, V Journal: Annals of oncology Issue: Volume 29(2018)Supplement 8 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Three- versus six-month adjuvant FOLFOX or CAPOX for high-risk stage II and stage III colon cancer patients: the efficacy results of Hellenic Oncology Research Group (HORG) participation to the International Duration Evaluation of Adjuvant Chemotherapy (IDEA) project. (22nd June 2019) Authors: Souglakos, J; Boukovinas, I; Kakolyris, S; Xynogalos, S; Ziras, N; Athanasiadis, A; Androulakis, N; Christopoulou, A; Vaslamatzis, M; Ardavanis, A; Emmanouilides, C; Bompolaki, I; Kourousis, C; Makrantonakis, P; Christofyllakis, C; Athanasiadis, E; Kentepozidis, N; Karampeazis, A; Katopodi, U; An... Journal: Annals of oncology Issue: Volume 30:Number 8(2019) Page Start: 1304 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗